Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice

Guidelines on the management of chronic obstructive pulmonary disease (COPD) are based on numerous randomized, controlled trials of efficacy, which are usually generated for registration purposes. However, these trials have included patients who were selected with the use of strict criteria and were closely monitored, and therefore the results have limited relevance to everyday clinicalContinue reading “Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice”

One-year Mortality in COPD Exacerbation: The Effect of Physical Activity

One-year Mortality in COPD After an Exacerbation: The Effect of Physical Activity Changes During the Event (2016) Cristóbal Esteban , Susana Garcia-Gutierrez , Maria J Legarreta , Ane Anton-Ladislao , Nerea Gonzalez , Iratxe Lafuente , Nerea Fernandez de Larrea , Silvia Vidal , Marisa Bare , José M. Quintana , IRYSS -COPD group COPD: JournalContinue reading “One-year Mortality in COPD Exacerbation: The Effect of Physical Activity”

Hypothyroidism linked to COPD exacerbation risk

Research shows that chronic obstructive pulmonary disease (COPD) patients with hypothyroidism have an elevated exacerbation frequency but, despite this, experience similar quality of life to patients with normal thyroid function. The research team, led by Sevinc Sarinc Ulasli (Afyon Kocatepe University, Turkey), studied a group of 44 COPD patients with hypothyroidism, 44 with COPD andContinue reading “Hypothyroidism linked to COPD exacerbation risk”